e-learning
resources
Vienna 2009
Monday, 14.09.2009
Inflammation and airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristic pattern of lipoxygenase products in exhaled breath condensates from patients with Churge-Strauss syndrome
M. Sanak, L. Mastalerz, M. Kaszuba, B. Sokolowska, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland)
Source:
Annual Congress 2009 - Inflammation and airways
Session:
Inflammation and airways
Session type:
Thematic Poster Session
Number:
2119
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sanak, L. Mastalerz, M. Kaszuba, B. Sokolowska, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland). Characteristic pattern of lipoxygenase products in exhaled breath condensates from patients with Churge-Strauss syndrome. Eur Respir J 2009; 34: Suppl. 53, 2119
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Eicosanoids in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Inflammatory markers in exhaled breath condensate differ between pre-school children with and without recurrent wheeze
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
TNF-α in exhaled breath condensate and in serum of scleroderma patients
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003
Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004
Nitric oxide metabolites in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004
The differences in the arachidonate metabolites in breath condensates from patients with Churg-Strauss syndrome
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Correlation of F
E
NO with nitrites and nitrates in exhaled breath condensate in cystic fibrosis patients
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007
Effect of exercise on the levels of cyclooxygenase products in exhaled breath condensate in leading sportsmen
Source: Eur Respir J 2002; 20: Suppl. 38, 411s
Year: 2002
Leukotrienes in exhaled breath condensate of children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001
Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease?
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004
Supplementation with antioxidants in Down syndrome: the effects on exhaled breath condensate (EBC) and serum
Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Year: 2007
Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept